Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen, 600,000 Votes Shy, Seeks More Shareholder Input for Dec. 15 Merger Decision

NEW YORK, Dec. 14 (GenomeWeb News) - Nanogen needs around 600,000 shareholder votes for its special stockholder meeting on Dec. 15 to allow its merger with Epoch Biosciences to go forward, the company said today.


Shareholders will decide at the meeting whether to issue new shares of Nanogen common stock in connection with the merger, and whether to amend the Nanogen certificate of incorporation to expand the number of authorized shares, a prerequisite for the merger.


The meeting was adjourned on Dec. 8 and postponed until Dec. 15 because the number of shares represented by votes or votes by proxy was insufficient for a decision. As of now, shares represented by proxy are 600,000 votes shy of the necessary 16.7 million votes. Nanogen stockholders as of Oct. 26 are eligible for voting.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.